Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Completed · Phase 3

Conditions studied: COPD

In brief

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Key facts

Study ID

NCT02536508

Run by

Pearl Therapeutics, Inc.

People needed

627

Starts

2015-08-10

Expected to finish

2017-09-12

Last updated by the study team

2021-02-26

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Given their signed written informed consent to participate. Must have agreed to participate in and complete the lead-in Study PT010006.(NCT02497001)

You may not qualify if…

• Severe osteoporosis Unable to achieve an acceptable DEXA scan Inability to achieve pupil dilation to at least 6 mm Subjects with an implanted artificial intraocular lens or are scheduled to undergo cataract surgery

Where it is running

• Research Site — Jasper, Alabama, United States
• Research Site — Peoria, Arizona, United States
• Research Site — Phoenix, Arizona, United States
• Research Site — Fullerton, California, United States
• Research Site — Gold River, California, United States
• Research Site — Poway, California, United States
• Research Site — Rolling Hills Estates, California, United States
• Research Site — Sacramento, California, United States
• Research Site — Clearwater, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Ormond Beach, Florida, United States
• Research Site — Pensacola, Florida, United States
• Research Site — Tamarac, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Winter Park, Florida, United States
• Research Site — Dacula, Georgia, United States
• Research Site — Norcross, Georgia, United States
• Research Site — Rincon, Georgia, United States
• Research Site — Edina, Minnesota, United States
• Research Site — Minneapolis, Minnesota, United States
• Research Site — Minneapolis, Minnesota, United States
• Research Site — Woodbury, Minnesota, United States
• Research Site — Saint Charles, Missouri, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Dothan, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.